Francesco Costa

5PUBLICATIONS
43CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Gene and molecular therapyNanotoxicology, health and safetyNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 13, 2025
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Giammarco Mocci, Antonio Tursi, Franco Scaldaferri

|Dec 17, 2024
Associations Between Polymorphisms of Genes Related to Vitamin D Pathway and the Response to Vedolizumab and Ustekinumab in Inflammatory Bowel Disease.

Jessica Cusato, Davide Giuseppe Ribaldone, Antonio D Avolio

|Apr 27, 2024
Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study.

Jessica Cusato, Davide Giuseppe Ribaldone, Michela Helga Falzone

|Mar 28, 2024
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.

Luisa Bertin, Brigida Barberio, Alessandro Gubbiotti

|Oct 14, 2023
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn's Disease.

Lorenzo Bertani, Claudia D'Alessandro, Marco Fornili

Pageof 1

Frequent Collaborators

4 joint publications

Lorenzo Bertani

3 joint publications

Davide Giuseppe Ribaldone

2 joint publications

Antonio D'Avolio

2 joint publications

Gian Paolo Caviglia